Skip to content
healthcare.dev

VIMKUNYA

NDC 50632-018, Chikungunya Vaccine, Recombinant, injection, suspension, from Bavarian Nordic A/S.

Product NDC
50632-018
Status
Listed
Labeler
Bavarian Nordic A/S
Dosage form
INJECTION, SUSPENSION
Route
INTRAMUSCULAR
Product type
VACCINE
Marketing category
BLA
Application
BLA125820
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50632-018 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CHIKUNGUNYA VIRUS SENEGAL STRAIN 37997 CAPSID PROTEIN10 ug/.8mL
  • CHIKUNGUNYA VIRUS SENEGAL STRAIN 37997 ENVELOPE PROTEIN E115 ug/.8mL
  • CHIKUNGUNYA VIRUS SENEGAL STRAIN 37997 ENVELOPE PROTEIN E215 ug/.8mL
Package NDCNDC-11Package
50632-018-02506320018021 SYRINGE, GLASS in 1 CARTON (50632-018-02) / .8 mL in 1 SYRINGE, GLASS (50632-018-04)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 50632-018 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50632-018 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50632-018. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.